Stephenson Harwood’s Life Sciences & Healthcare team partnered with BiotechTV to discuss the key trends affecting investments into life sciences and healthcare companies, with a focus on cross-border and complex deal structures, exits and disputes.
Video can be seen below but key highlights include:
- The increasing complexity of deal structures, with more crossover between equity and licensing.
- Strategic decisions around partnering lead or backup assets, and how these impact future exit opportunities.
- The importance of thorough due diligence and understanding corporate structures, especially in cross-border deals with China and the Middle East.
- Market trends such as the growing focus on longevity, health, and opportunities in emerging regions.
- Key negotiation points, including deferred consideration, milestones, and the need for competitive tension in deal processes.
- The rise in disputes over royalties, milestones, and IP ownership, and how clear drafting can help avoid litigation.
Our team also shares practical tips on how to navigate these challenges and highlights how Stephenson Harwood can support you with cross-border expertise and sector insight.
We hope you find the video useful and thought-provoking as you prepare for upcoming industry events such as London Life Sciences Week and Jefferies Global Healthcare Conference.
If you have any questions or would like to discuss any of the topics covered, please don’t hesitate to get in touch.
